All GLG News Analyses Filed Under: Infectious Disease

The data presented by this Spanish study shows that an immune enhanced influenza vaccine likely decreases hospitalization by decreasing the inflammatory reaction that is associated with influenza. This is required in those with decreased immune responses,i.e., the elderly. In younger individuals it...

I am not impressed. I am wandering why the responces were so low in non-respoders. will be happy to discuss

-Menactra recently gained approval for children 2-10 years old -Unless the ACIP changes its recommended age for routine use (currently 11), this will have little impact -Most children will only need this in this expanded age range for travel to some parts of the world.

Many are colonized with MRSA< just as with other staph, but relatively few get disease.

Meningococcal disease is rare but devastating, and any available method for reduction of the disease is welcome.   

* MRSA is a serious problem in the US, particularly with the increasing spread of community acquired strains (caMRSA). * Toxins produced by many caMRSA are rapidly lethal in populations who get soft-tissue infections or sepsis from these organisms (children, elderly). * Nosocomically-acquired MRSAs...

MRSA is a significant pathogen now spreading from the hospital into the community. Physicians need to think of this now everytime they deal with a soift tiisue infection. Not treating it properly can lead to dire consequences. Infection control schema now need to be inrtoduced into schools as well....

The news published in the Medical News (11/10/2007) is an important piece of information on the use of IMVAMUNE(R) Smallpox Vaccine for patients with atopic dermatitis. This would definitely support the US Govt., particularly, The National Institutes of Allergy and Infectious Diseases (NIAID) unit's...

A recent abstract for the 2007 Infectious Diseases Society of American (IDSA) meeting has generated some concern among financial analysts.  This non-inferiority study on iclaprim versus linezolid for treatment of complicated skin and skin structure infections showed that “The 95% CI for treatment...

The only issue that will arise is safety. What will be the reaction to the monoclonal  antibodies and what are the potential downsides. Cost of this therapy may be limiting as well.